Perrigo Company PLC
$ 14.55
-2.81%
23 Feb - close price
- Market Cap 2,002,429,000 USD
- Current Price $ 14.55
- High / Low $ 15.03 / 14.54
- Stock P/E N/A
- Book Value 32.31
- EPS -0.21
- Next Earning Report 2026-02-26
- Dividend Per Share $1.16
- Dividend Yield 7.78 %
- Next Dividend Date 2026-03-24
- ROA 0.03 %
- ROE -0.01 %
- 52 Week High 29.27
- 52 Week Low 11.91
About
Perrigo Company plc is an American Irish registered manufacturer of private label over-the-counter pharmaceuticals.
Analyst Target Price
$21.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-05 | 2025-08-06 | 2025-05-02 | 2025-02-27 | 2024-11-06 | 2024-08-02 | 2024-05-07 | 2024-02-27 | 2023-11-07 | 2023-08-08 | 2023-05-09 | 2023-02-27 |
| Reported EPS | 0.8 | 0.57 | 0.6 | 0.36 | 0.81 | 0.53 | 0.29 | 0.86 | 0.64 | 0.63 | 0.45 | 0.75 |
| Estimated EPS | 0.76 | 0.59 | 0.5658 | 0.95 | 0.83 | 0.46 | 0.23 | 0.83 | 0.63 | 0.51 | 0.42 | 0.71 |
| Surprise | 0.04 | -0.02 | 0.0342 | -0.59 | -0.02 | 0.07 | 0.06 | 0.03 | 0.01 | 0.12 | 0.03 | 0.04 |
| Surprise Percentage | 5.2632% | -3.3898% | 6.0445% | -62.1053% | -2.4096% | 15.2174% | 26.087% | 3.6145% | 1.5873% | 23.5294% | 7.1429% | 5.6338% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-26 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.8 |
| Currency | USD |
Previous Dividend Records
| Mar 2026 | Dec 2025 | Jan 1970 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-24 | 2025-12-16 | None | 2025-06-17 | 2025-03-25 | 2024-12-17 | 2024-09-17 | 2024-06-18 | 2024-03-26 | 2023-12-19 |
| Amount | $0.29 | $0.29 | $0.29 | $0.29 | $0.29 | $0.276 | $0.276 | $0.276 | $0.276 | $0.273 |
Next Dividend Records
| Dividend per share (year): | $1.16 |
| Dividend Yield | 7.78% |
| Next Dividend Date | 2026-03-24 |
| Ex-Dividend Date | 2026-03-02 |
Recent News: PRGO
2026-02-21 15:21:30
Perrigo Co. plc announced plans to sell its HRA Pharma Rare Diseases unit to Spanish pharmaceutical company Esteve Healthcare S.L. for up to $293.9 million. The sale, expected to close in Q3 2024, includes an upfront cash payment of $203 million and potential earnouts, with the proceeds intended to reduce Perrigo's long-term debt. This divestiture aligns with Perrigo's strategy to focus on its fast-moving consumer goods business.
2026-02-20 00:56:56
Perrigo Company plc (NYSE:PRGO) has declared a quarterly dividend of $0.29 per share, payable on March 24, 2026, to shareholders of record on March 2, 2026. This represents an annualized dividend of $1.16 and a dividend yield of 7.8%. The company has a history of consistently increasing its dividend, with 23 consecutive years of raises.
2026-02-19 17:00:56
Perrigo Company plc (NYSE: PRGO) has announced that its Board of Directors approved a quarterly dividend of $0.29 per share, or $1.16 per share on an annualized basis. The cash dividend is slated for payment on March 24, 2026, to shareholders recorded by March 2, 2026. Perrigo identifies as a leading pure-play consumer health company, offering high-quality health and wellness solutions primarily in North America and Europe.
2026-02-19 16:29:46
Perrigo (PRGO) is expected to report a year-over-year decline in Q4 earnings and revenues, with an estimated EPS of $0.80, down 14%, and revenues of $1.1 billion, down 3.2%. The Zacks Earnings ESP is 0%, and with a Zacks Rank #2, it's difficult to conclusively predict an earnings beat despite the company beating consensus EPS estimates in three of the last four quarters. Investors are advised to consider other factors beyond just earnings surprise history.
2026-02-19 14:27:46
Perrigo Company plc announced a quarterly cash dividend of $0.29 per share, totaling an annualized payout of $1.16 per share. This dividend is scheduled to be paid on March 24, 2026, to shareholders of record as of March 2, 2026. The announcement reaffirms Perrigo's focus as a pure-play consumer health company, leveraging its private-label offerings to invest in leading brands.
2026-02-19 14:27:46
Perrigo Company plc announced a quarterly dividend of $0.29 per share, totaling $1.16 annually, which offers a 7.96% yield. The dividend is payable on March 24, 2026, to shareholders of record by March 2, 2026, continuing the company's 23-year streak of dividend payments. This news follows a recent downgrade in Perrigo's credit rating and revised fiscal guidance due to challenges in the infant nutrition sector.
